• Facebook
  • X
  • Instagram
MYELOMA360
  • Home
  • MYInsights
  • MYBoard
  • Strategy & Consulting
Select Page

Genomic landscape of multiple myeloma and its precursor conditions

by MM360 Staff | May 22, 2025 | Myeloma News

Source: Myeloma : nature.com subject feeds Post Content Read More

Managing Opioid Complexity: The Role of Pharmacists in OUD and C-POD Care

by MM360 Staff | May 21, 2025 | Myeloma News

Source: Pharmacy Times articles In a session at the 2025 Virtual Conference on Pain and Palliative Care, Isabella Zerfas, PharmD, and Abbey Galligan, PharmD, BCPS, explore effective pain management strategies for opioid use disorder (OUD) and complex persistent opioid...

FDA to Restrict Future COVID-19 Vaccine Recommendations to Older Adults, High-Risk Groups

by MM360 Staff | May 21, 2025 | Myeloma News

Source: Pharmacy Times articles In a major policy shift, officials from the FDA announced a new regulatory framework for COVID-19 vaccinations, prioritizing adults aged 65 and older and individuals with serious comorbidities putting them at high risk for severe...

Lucy Phan Vo, PharmD, BCPS, BCEMP, on Advancing Pharmacy Practice Through Education

by MM360 Staff | May 21, 2025 | Myeloma News

Source: Pharmacy Times articles Vo discusses how research and mentorship can enhance practice and patient care. Read More

Expert Shares RSV Vaccination Strategies for Older Adults: Recommendations and Patient Engagement

by MM360 Staff | May 21, 2025 | Myeloma News

Source: Pharmacy Times articles RSV vaccination for older adults requires understanding risk factors, using empathetic communication strategies and proactively identifying eligible patients through careful review of medical histories and care transitions. Read...

Experts Share 2025 Pneumococcal Vaccination Guideline Recommendations for Children, Adolescents, and Adults

by MM360 Staff | May 21, 2025 | Myeloma News

Source: Pharmacy Times articles Experts emphasize the importance of tailored vaccination strategies for pneumococcal based on individual risk factors. Read More
« Older Entries
Next Entries »

Recent Content

  • Prognostic and clinicopathological value of prognostic nutritional index in patients with multiple myeloma: a meta-analysis
  • Daratumumab plus lenalidomide maintenance in newly diagnosed multiple myeloma after transplant: AURIGA subgroup analyses
  • Randomized Phase 3 study of pomalidomide cyclophosphamide dexamethasone versus pomalidomide dexamethasone in relapse or refractory myeloma: an Asian Myeloma Network study (AMN003)
  • (no title)
  • The risk of second primary malignancies in patients receiving T-cell directed therapies for multiple myeloma: a systematic review
  • (no title)
  • Impact of residual clonal plasma cells in S-phase at the time of autologous stem cell transplantation on clinical outcomes
  • (no title)
  • Efficacy and toxicity of treatment of smoldering multiple myeloma: a systematic review and meta-analysis
  • (no title)
  • Facebook
  • X
  • Instagram
©2016-2025 MYELOMA360 & Connect BioMed
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.
Do not sell my personal information.
SettingsAccept
Privacy & Cookies Policy

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Non-necessary
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
SAVE & ACCEPT